Schedule a Call Back
India urged to expand local vaccine manufacturing and research: GTRI
Articles- Nov 12,24
The think tank recommended that the Indian government investigate all adverse health events post-vaccination.
India should focus on expanding its local vaccine manufacturing and research capabilities to enhance control over the safety and effectiveness of pharmaceutical products, according to a report by the Global Trade Research Initiative (GTRI).
The think tank recommended that the Indian government investigate all adverse health events post-vaccination. This step, it suggests, could improve the transparency, safety, and efficacy of future vaccine rollouts.
“Expanding local vaccine production and research will enable India to better address vaccine safety, ensuring that vaccines are tailored to the country's specific health needs and population characteristics,” the report stated.
This call for expansion gains further relevance following the release of The Pfizer Papers: Crimes Against Humanity in October 2024, which has sparked global debate on vaccine safety, ethics, and transparency.
Ajay Srivastava, Founder, GTRI, emphasised, “As the world prepares for future pandemics, insights from The Pfizer Papers can lay the groundwork for safer, more effective, and more trustworthy vaccination strategies, prioritising public health over profit in global health responses.”
(Business Standard)
Related Stories
Process Equipment
Lupin’s ESG score rises to 76 in S&P Global ESG Ratings
A strong sustainability framework is at the heart of Lupin’s strategy and the company has integrated it in all its business operations.
Read morePolicy Regulation
Port delays and regulations strain India’s steel user industries: GTRI
Policies designed to protect domestic steelmakers, such as import restrictions and quality control measures, have inadvertently hurt industries dependent on imported steel, undermining their product..
Read moreProcess Equipment
AptarGroup breaks ground on new pharma plant in Taloja, near Mumbai
Spanning 4,400 square metres, the new plant will be constructed adjacent to Aptar's existing Mumbai facility, which opened in 2023.
Read moreRelated Products
Programmable Controllers - Pcd-33a Series
CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS
Pro-Med Instruments (P) Ltd offers a wide range of programmable controllers - PCD-33A Series.
Gasket Graphite Powder
CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS
Arihant Packing & Gasket Company offers a wide range of gasket graphite powder.
Asahi Kasei expands 3D printing filament sales in North America
CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS
Asahi Kasei, a leading resin and compounding technology provider, has initiated the sales of 3D printing (3DP) filaments in North America through Asahi Kasei Plastics North America (APNA). The soft la Read more
latest News
Subscribe to iNoW
For Industry News on WhatsApp, Give a Miss Call on: +91 84228 74016
